Surdziel Ewa, Clay Ieuan, Nigsch Florian, Thiemeyer Anke, Allard Cyril, Hoffman Gregory, Reece-Hoyes John S, Phadke Tanushree, Gambert Romain, Keller Caroline Gubser, Ludwig Marie-Gabrielle, Baumgarten Birgit, Frederiksen Mathias, Schübeler Dirk, Seuwen Klaus, Bouwmeester Tewis, Fodor Barna D
Novartis Institutes for Biomedical Research, Basel, Switzerland.
Novartis Institutes for Biomedical Research, Cambridge, United States of America.
PLoS One. 2017 Aug 24;12(8):e0183679. doi: 10.1371/journal.pone.0183679. eCollection 2017.
Macrophages are key cell types of the innate immune system regulating host defense, inflammation, tissue homeostasis and cancer. Within this functional spectrum diverse and often opposing phenotypes are displayed which are dictated by environmental clues and depend on highly plastic transcriptional programs. Among these the 'classical' (M1) and 'alternative' (M2) macrophage polarization phenotypes are the best characterized. Understanding macrophage polarization in humans may reveal novel therapeutic intervention possibilities for chronic inflammation, wound healing and cancer. Systematic loss of function screening in human primary macrophages is limited due to lack of robust gene delivery methods and limited sample availability. To overcome these hurdles we developed cell-autonomous assays using the THP-1 cell line allowing genetic screens for human macrophage phenotypes. We screened 648 chromatin and signaling regulators with a pooled shRNA library for M1 and M2 polarization modulators. Validation experiments confirmed the primary screening results and identified OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) as a novel mediator of M2 polarization in human macrophages. Our approach offers a possible avenue to utilize comprehensive genetic tools to identify novel candidate genes regulating macrophage polarization in humans.
巨噬细胞是先天性免疫系统的关键细胞类型,可调节宿主防御、炎症、组织稳态和癌症。在这个功能范围内,巨噬细胞表现出多样且常常相互对立的表型,这些表型由环境线索决定,并依赖于高度可塑性的转录程序。其中,“经典”(M1)和“替代”(M2)巨噬细胞极化表型的特征最为明显。了解人类巨噬细胞极化可能会揭示针对慢性炎症、伤口愈合和癌症的新型治疗干预可能性。由于缺乏强大的基因递送方法和有限的样本可用性,人类原代巨噬细胞中的系统功能丧失筛选受到限制。为了克服这些障碍,我们利用THP-1细胞系开发了细胞自主检测方法,用于对人类巨噬细胞表型进行基因筛选。我们用一个汇集的shRNA文库筛选了648个染色质和信号调节因子,以寻找M1和M2极化调节剂。验证实验证实了初步筛选结果,并确定OGT(O-连接的N-乙酰葡糖胺(GlcNAc)转移酶)是人类巨噬细胞中M2极化的新型调节因子。我们的方法为利用综合遗传工具来鉴定调节人类巨噬细胞极化的新候选基因提供了一条可能的途径。